Skip to content

Author

K. Gebo

We have 2 of 354 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Changes in HIV Clinical Visit Frequency and Viral Suppression During and After COVID-19 Restrictions: A Nested Study Within NA-ACCORD in the US, 2018–2021

Abstract Background Temporary COVID-19-related restrictions disrupted routine HIV care and viral load (VL) testing for people with HIV (PWH). Whether and when encounters and VL suppression returned to prepandemic levels remains unclear. We aimed to evaluate changes in HIV clinical encounter frequency and VL suppression...

Yue Zhang, Breanna Hogan, K. Gebo et al. · 0 citations
Open access Aug 2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

BACKGROUND Post-acute sequelae of SARS-CoV-2 infection, more commonly known as long COVID, has emerged as a major health problem. The pathogenesis of long COVID is unknown, but among the leading hypotheses is viral persistence. We aimed to investigate whether the use of the SARS-CoV-2 antiviral nirmatrelvir-ritonavir i...

L. Baden, N. Shah, Sean T. H. Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.